The regulation of bone metabolism and disorders by Wnt signaling

K Maeda, Y Kobayashi, M Koide, S Uehara… - International journal of …, 2019 - mdpi.com
Wnt, a secreted glycoprotein, has an approximate molecular weight of 40 kDa, and it is a
cytokine involved in various biological phenomena including ontogeny, morphogenesis …

Osteoporosis: current concepts

I Akkawi, H Zmerly - Joints, 2018 - thieme-connect.com
Osteoporosis is a worldwide disease characterized by reduction of bone mass and alteration
of bone architecture resulting in increased bone fragility and increased fracture risk. Causes …

Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment

L Hu, C Yin, F Zhao, A Ali, J Ma, A Qian - International Journal of …, 2018 - mdpi.com
Osteoporosis is a progressive skeletal disease characterized by decreased bone mass and
degraded bone microstructure, which leads to increased bone fragility and risks of bone …

Autophagy controls mesenchymal stem cell properties and senescence during bone aging

Y Ma, M Qi, Y An, L Zhang, R Yang, DH Doro, W Liu… - Aging cell, 2018 - Wiley Online Library
Bone marrow‐derived mesenchymal stem cells (BMMSC s) exhibit degenerative changes,
including imbalanced differentiation and reduced proliferation during aging, that contribute …

RANKL biology: bone metabolism, the immune system, and beyond

T Ono, M Hayashi, F Sasaki, T Nakashima - Inflammation and …, 2020 - Springer
Receptor activator of NF-κB (RANK) ligand (RANKL) induces the differentiation of monocyte/
macrophage–lineage cells into the bone–resorbing cells called osteoclasts. Because …

Osteoporosis therapies and their mechanisms of action

B Kim, YJ Cho, W Lim - Experimental and therapeutic …, 2021 - spandidos-publications.com
Osteoporosis is a common disease that affects millions of patients worldwide and is most
common in menopausal women. The main characteristics of osteoporosis are low bone …

[HTML][HTML] Autophagy maintains the function of bone marrow mesenchymal stem cells to prevent estrogen deficiency-induced osteoporosis

M Qi, L Zhang, Y Ma, Y Shuai, L Li, K Luo, W Liu… - Theranostics, 2017 - ncbi.nlm.nih.gov
Rationale: The impaired function of endogenous bone marrow mesenchymal stem cells
(BMMSCs) is a determinant in the development of osteoporosis (OP). Recent researches …

Pharmacological therapy of osteoporosis: a systematic current review of literature

V Pavone, G Testa, SMC Giardina, A Vescio… - Frontiers in …, 2017 - frontiersin.org
Osteoporosis is the most common bone disease affecting millions of people worldwide,
particularly in elderly or in post-menopausal women. The pathogenesis is useful to …

Review on the protective activity of osthole against the pathogenesis of osteoporosis

J Chen, X Liao, J Gan - Frontiers in Pharmacology, 2023 - frontiersin.org
Osteoporosis (OP), characterized by continuous bone loss and increased fracture risk, has
posed a challenge to patients and society. Long-term administration of current …

Exercise for optimizing bone health after hormone-induced increases in bone stiffness

JM Hughes, KI Guerriere, KL Popp… - Frontiers in …, 2023 - frontiersin.org
Hormones and mechanical loading co-regulate bone throughout the lifespan. In this review,
we posit that times of increased hormonal influence on bone provide opportunities for …